Philipp Freese
Corporate Officer/Principal bei MAINZ BIOMED N.V.
Vermögen: 310 210 $ am 30.04.2024
Aktive Positionen von Philipp Freese
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MAINZ BIOMED N.V. | Corporate Officer/Principal | 01.07.2023 | - |
Geschäftsführer | 01.02.2015 | 01.07.2023 | |
PharmGenomics GmbH
PharmGenomics GmbH Medical SpecialtiesHealth Technology PharmGenomics GmbH develops diagnostic systems. Its offers PGx GenoChips and software. The firm also provides contract development and laboratory services. The company was founded by Moritz Eidens in 2008 and is headquartered in Maiz, Germany. | Vorstandsvorsitzender | - | - |
Direktor/Vorstandsmitglied | - | - | |
Corporate Officer/Principal | 01.01.2015 | - | |
Vertrieb & Marketing | 01.01.2013 | 01.01.2015 |
Karriereverlauf von Philipp Freese
Statistik
International
Deutschland | 3 |
Operativ
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MAINZ BIOMED N.V. | Health Technology |
Private Unternehmen | 1 |
---|---|
PharmGenomics GmbH
PharmGenomics GmbH Medical SpecialtiesHealth Technology PharmGenomics GmbH develops diagnostic systems. Its offers PGx GenoChips and software. The firm also provides contract development and laboratory services. The company was founded by Moritz Eidens in 2008 and is headquartered in Maiz, Germany. | Health Technology |
- Börse
- Insiders
- Philipp Freese
- Erfahrung